Exploring the Dual Roles of Neural Stem Cells in Glioblastoma: Therapeutic Implications and Opportunities

Couturier, C.P.; Ayyadhury, S.; Le, P.U.; Nadaf, J.; Monlong, J.; Riva, G.; Allache, R.; Baig, S.; Yan, X.; Bourgey, M.; Lee, C.; Wang, Y.C.D.; Yong, W.V.; Guiot, M-C.; Najafabadi, H.; Misic, B.; Antel, J.; Bourque, G.; Ragoussis, J.; Petrecca, K. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. Nat. Commun., 2020, 11(1), 3406.
[http://dx.doi.org/10.1038/s41467-020-17186-5]

Ostrom, Q.T.; Cioffi, G.; Gittleman, H.; Patil, N.; Waite, K.; Kruchko, C.; Sloan, B.J.S. CBTRUS Statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-oncol., 2019, 21(S5), v1-v100.
[http://dx.doi.org/10.1093/neuonc/noz150] [PMID: 31675094]

Louis, D.N.; Perry, A.; Reifenberger, G.; Deimling, v.A.; Branger, F.D.; Cavenee, W.K.; Ohgaki, H.; Wiestler, O.D.; Kleihues, P.; Ellison, D.W. The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol., 2016, 131(6), 803-820.
[http://dx.doi.org/10.1007/s00401-016-1545-1] [PMID: 27157931]

Sánchez, S.J.M.; Langa, M.J.; Arráez, M.Á.; Fuster, J.; Laín, H.A.; Reynés, G.; González, R.V.; Vicente, E.; Denis, V.M.; Gallego, Ó. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017). Clin. Transl. Oncol., 2018, 20(1), 3-15.
[http://dx.doi.org/10.1007/s12094-017-1790-3] [PMID: 29124520]

Brain tumours (Primary) and brain metastases in adults; National Institute for Health and Care Excellence: London, UK, 2018.

Stupp, R.; Brada, M.; van den Bent, M.J.; Tonn, J.C.; Pentheroudakis, G. High-grade glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2014, 25(S3), iii93-iii101.
[http://dx.doi.org/10.1093/annonc/mdu050] [PMID: 24782454]

Taylor, O.G.; Brzozowski, J.S.; Skelding, K.A. Glioblastoma multiforme: An overview of emerging therapeutic targets. Front. Oncol., 2019, 9, 963.
[http://dx.doi.org/10.3389/fonc.2019.00963] [PMID: 31616641]

Shah, K. Stem cell-based therapies for tumors in the brain: Are we there yet? Neuro-oncol., 2016, 18(8), 1066-1078.
[http://dx.doi.org/10.1093/neuonc/now096] [PMID: 27282399]

Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol., 2007, 114(2), 97-109.
[http://dx.doi.org/10.1007/s00401-007-0243-4] [PMID: 17618441]

Parker, N.R.; Khong, P.; Parkinson, J.F.; Howell, V.M.; Wheeler, H.R. Molecular heterogeneity in glioblastoma: Potential clinical implications. Front. Oncol., 2015, 5, 55.
[http://dx.doi.org/10.3389/fonc.2015.00055] [PMID: 25785247]

Brennan, C.W.; Verhaak, R.G.W.; McKenna, A.; Campos, B.; Noushmehr, H.; Salama, S.R.; Zheng, S.; Chakravarty, D.; Sanborn, J.Z.; Berman, S.H.; Beroukhim, R.; Bernard, B.; Wu, C.J.; Genovese, G.; Shmulevich, I.; Sloan, B.J.; Zou, L.; Vegesna, R.; Shukla, S.A.; Ciriello, G.; Yung, W.K.; Zhang, W.; Sougnez, C.; Mikkelsen, T.; Aldape, K.; Bigner, D.D.; Meir, V.E.G.; Prados, M.; Sloan, A.; Black, K.L.; Eschbacher, J.; Finocchiaro, G.; Friedman, W.; Andrews, D.W.; Guha, A.; Iacocca, M.; O’Neill, B.P.; Foltz, G.; Myers, J.; Weisenberger, D.J.; Penny, R.; Kucherlapati, R.; Perou, C.M.; Hayes, D.N.; Gibbs, R.; Marra, M.; Mills, G.B.; Lander, E.; Spellman, P.; Wilson, R.; Sander, C.; Weinstein, J.; Meyerson, M.; Gabriel, S.; Laird, P.W.; Haussler, D.; Getz, G.; Chin, L.; Benz, C.; Sloan, B.J.; Barrett, W.; Ostrom, Q.; Wolinsky, Y.; Black, K.L.; Bose, B.; Boulos, P.T.; Boulos, M.; Brown, J.; Czerinski, C.; Eppley, M.; Iacocca, M.; Kempista, T.; Kitko, T.; Koyfman, Y.; Rabeno, B.; Rastogi, P.; Sugarman, M.; Swanson, P.; Yalamanchii, K.; Otey, I.P.; Liu, Y.S.; Xiao, Y.; Auman, J.T.; Chen, P-C.; Hadjipanayis, A.; Lee, E.; Lee, S.; Park, P.J.; Seidman, J.; Yang, L.; Kucherlapati, R.; Kalkanis, S.; Mikkelsen, T.; Poisson, L.M.; Raghunathan, A.; Scarpace, L.; Bernard, B.; Bressler, R.; Eakin, A.; Iype, L.; Kreisberg, R.B.; Leinonen, K.; Reynolds, S.; Rovira, H.; Thorsson, V.; Shmulevich, I.; Annala, M.J.; Penny, R.; Paulauskis, J.; Curley, E.; Hatfield, M.; Mallery, D.; Morris, S.; Shelton, T.; Shelton, C.; Sherman, M.; Yena, P.; Cuppini, L.; DiMeco, F.; Eoli, M.; Finocchiaro, G.; Maderna, E.; Pollo, B.; Saini, M.; Balu, S.; Hoadley, K.A.; Li, L.; Miller, C.R.; Shi, Y.; Topal, M.D.; Wu, J.; Dunn, G.; Giannini, C.; O’Neill, B.P.; Aksoy, B.A.; Antipin, Y.; Borsu, L.; Berman, S.H.; Brennan, C.W.; Cerami, E.; Chakravarty, D.; Ciriello, G.; Gao, J.; Gross, B.; Jacobsen, A.; Ladanyi, M.; Lash, A.; Liang, Y.; Reva, B.; Sander, C.; Schultz, N.; Shen, R.; Socci, N.D.; Viale, A.; Ferguson, M.L.; Chen, Q-R.; Demchok, J.A.; Dillon, L.A.L.; Shaw, K.R.M.; Sheth, M.; Tarnuzzer, R.; Wang, Z.; Yang, L.; Davidsen, T.; Guyer, M.S.; Ozenberger, B.A.; Sofia, H.J.; Bergsten, J.; Eckman, J.; Harr, J.; Myers, J.; Smith, C.; Tucker, K.; Winemiller, C.; Zach, L.A.; Ljubimova, J.Y.; Eley, G.; Ayala, B.; Jensen, M.A.; Kahn, A.; Pihl, T.D.; Pot, D.A.; Wan, Y.; Eschbacher, J.; Foltz, G.; Hansen, N.; Hothi, P.; Lin, B.; Shah, N.; Yoon, J.; Lau, C.; Berens, M.; Ardlie, K.; Beroukhim, R.; Carter, S.L.; Cherniack, A.D.; Noble, M.; Cho, J.; Cibulskis, K.; DiCara, D.; Frazer, S.; Gabriel, S.B.; Gehlenborg, N.; Gentry, J.; Heiman, D.; Kim, J.; Jing, R.; Lander, E.S.; Lawrence, M.; Lin, P.; Mallard, W.; Meyerson, M.; Onofrio, R.C.; Saksena, G.; Schumacher, S.; Sougnez, C.; Stojanov, P.; Tabak, B.; Voet, D.; Zhang, H.; Zou, L.; Getz, G.; Dees, N.N.; Ding, L.; Fulton, L.L.; Fulton, R.S.; Kanchi, K-L.; Mardis, E.R.; Wilson, R.K.; Baylin, S.B.; Andrews, D.W.; Harshyne, L.; Cohen, M.L.; Devine, K.; Sloan, A.E.; VandenBerg, S.R.; Berger, M.S.; Prados, M.; Carlin, D.; Craft, B.; Ellrott, K.; Goldman, M.; Goldstein, T.; Grifford, M.; Haussler, D.; Ma, S.; Ng, S.; Salama, S.R.; Sanborn, J.Z.; Stuart, J.; Swatloski, T.; Waltman, P.; Zhu, J.; Foss, R.; Frentzen, B.; Friedman, W.; McTiernan, R.; Yachnis, A.; Hayes, D.N.; Perou, C.M.; Zheng, S.; Vegesna, R.; Mao, Y.; Akbani, R.; Aldape, K.; Bogler, O.; Fuller, G.N.; Liu, W.; Liu, Y.; Lu, Y.; Mills, G.; Protopopov, A.; Ren, X.; Sun, Y.; Wu, C-J.; Yung, W.K.A.; Zhang, W.; Zhang, J.; Chen, K.; Weinstein, J.N.; Chin, L.; Verhaak, R.G.W.; Noushmehr, H.; Weisenberger, D.J.; Bootwalla, M.S.; Lai, P.H.; Triche, T.J., Jr; Van Den Berg, D.J.; Laird, P.W.; Gutmann, D.H.; Lehman, N.L.; VanMeir, E.G.; Brat, D.; Olson, J.J.; Mastrogianakis, G.M.; Devi, N.S.; Zhang, Z.; Bigner, D.; Lipp, E.; McLendon, R. The somatic genomic landscape of glioblastoma. Cell, 2013, 155(2), 462-477.
[http://dx.doi.org/10.1016/j.cell.2013.09.034] [PMID: 24120142]

Kroonen, J.; Nassen, J.; Boulanger, Y.G.; Provenzano, F.; Capraro, V.; Bours, V.; Martin, D.; Deprez, M.; Robe, P.; Rogister, B. Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. Int. J. Cancer, 2011, 129(3), 574-585.
[http://dx.doi.org/10.1002/ijc.25709] [PMID: 20886597]

Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; Vitis, D.S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res., 2004, 64(19), 7011-7021.
[http://dx.doi.org/10.1158/0008-5472.CAN-04-1364] [PMID: 15466194]

Llaguno, A.S.; Chen, J.; Kwon, C.H.; Jackson, E.L.; Li, Y.; Burns, D.K.; Buylla, A.A.; Parada, L.F. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell, 2009, 15(1), 45-56.
[http://dx.doi.org/10.1016/j.ccr.2008.12.006] [PMID: 19111880]

Lee, J.H.; Lee, J.E.; Kahng, J.Y.; Kim, S.H.; Park, J.S.; Yoon, S.J.; Um, J.Y.; Kim, W.K.; Lee, J.K.; Park, J.; Kim, E.H.; Lee, J.H.; Lee, J.H.; Chung, W.S.; Ju, Y.S.; Park, S.H.; Chang, J.H.; Kang, S.G.; Lee, J.H. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature, 2018, 560(7717), 243-247.
[http://dx.doi.org/10.1038/s41586-018-0389-3] [PMID: 30069053]

Kriegstein, A.; Buylla, A.A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci., 2009, 32(1), 149-184.
[http://dx.doi.org/10.1146/annurev.neuro.051508.135600] [PMID: 19555289]

Noctor, S.C.; Cerdeño, M.V.; Ivic, L.; Kriegstein, A.R. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat. Neurosci., 2004, 7(2), 136-144.
[http://dx.doi.org/10.1038/nn1172] [PMID: 14703572]

Qian, X.; Goderie, S.K.; Shen, Q.; Stern, J.H.; Temple, S. Intrinsic programs of patterned cell lineages in isolated vertebrate CNS ventricular zone cells. Development, 1998, 125(16), 3143-3152.
[http://dx.doi.org/10.1242/dev.125.16.3143] [PMID: 9671587]

Merkle, F.T.; Tramontin, A.D.; Verdugo, G.J.M.; Buylla, A.A. Radial glia give rise to adult neural stem cells in the subventricular zone. Proc. Natl. Acad. Sci., 2004, 101(50), 17528-17532.
[http://dx.doi.org/10.1073/pnas.0407893101] [PMID: 15574494]

Götz, M.; Barde, Y-A. Radial glial cells defined and major intermediates between embryonic stem cells and CNS neurons. Neuron, 2005, 46(3), 369-372.
[PMID: 15882633]

Doetsch, F.; Caillé, I.; Lim, D.A.; Verdugo, G.J.M.; Buylla, A.A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell, 1999, 97(6), 703-716.
[http://dx.doi.org/10.1016/S0092-8674(00)80783-7] [PMID: 10380923]

Gage, F.H.; Temple, S. Neural stem cells: Generating and regenerating the brain. Neuron, 2013, 80(3), 588-601.
[http://dx.doi.org/10.1016/j.neuron.2013.10.037] [PMID: 24183012]

Ge, W.P.; Miyawaki, A.; Gage, F.H.; Jan, Y.N.; Jan, L.Y. Local generation of glia is a major astrocyte source in postnatal cortex. Nature, 2012, 484(7394), 376-380.
[http://dx.doi.org/10.1038/nature10959] [PMID: 22456708]

Imamoto, K.; Leblond, C.P. Radioautographic investigation of gliogenesis in the corpus callosum of young rats II. Origin of microglial cells. J. Comp. Neurol., 1978, 180(1), 139-163.
[http://dx.doi.org/10.1002/cne.901800109] [PMID: 649786]

Bardehle, S.; Krüger, M.; Buggenthin, F.; Schwausch, J.; Ninkovic, J.; Clevers, H.; Snippert, H.J.; Theis, F.J.; Luehmann, M.M.; Bechmann, I.; Dimou, L.; Götz, M. Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat. Neurosci., 2013, 16(5), 580-586.
[http://dx.doi.org/10.1038/nn.3371] [PMID: 23542688]

Kiaie, N.; Gorabi, A.M.; Loveless, R.; Teng, Y.; Jamialahmadi, T.; Sahebkar, A. The regenerative potential of glial progenitor cells and reactive astrocytes in CNS injuries. Neurosci. Biobehav. Rev., 2022, 140, 104794.
[http://dx.doi.org/10.1016/j.neubiorev.2022.104794] [PMID: 35902044]

Loras, A.; Bonet, G.L.; Arroyo, G.J.; Cadenas, M.C.; Torrejon, M.M. Neural stem cells as potential glioblastoma cells of origin. Life, 2023, 13(4), 905.
[http://dx.doi.org/10.3390/life13040905] [PMID: 37109434]

Rodriguez, S.M.B.; Staicu, G.A.; Sevastre, A.S.; Baloi, C.; Ciubotaru, V.; Dricu, A.; Tataranu, L.G. Glioblastoma stem cells—useful tools in the battle against cancer. Int. J. Mol. Sci., 2022, 23(9), 4602.
[http://dx.doi.org/10.3390/ijms23094602] [PMID: 35562993]

Yang, X.; Klein, R.; Tian, X.; Cheng, H.T.; Kopan, R.; Shen, J. Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev. Biol., 2004, 269(1), 81-94.
[http://dx.doi.org/10.1016/j.ydbio.2004.01.014] [PMID: 15081359]

Hori, K.; Sen, A.; Tsakonas, A.S. Notch signaling at a glance. J. Cell Sci., 2013, 126(Pt 10), 2135-2140.
[PMID: 23729744]

LeBon, L.; Lee, T.V.; Sprinzak, D.; Nejad, J.H.; Elowitz, M.B. Fringe proteins modulate Notch-ligand cis and trans interactions to specify signaling states. eLife, 2014, 3, e02950.
[http://dx.doi.org/10.7554/eLife.02950] [PMID: 25255098]

Kopan, R.; Ilagan, M.X.G. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell, 2009, 137(2), 216-233.
[http://dx.doi.org/10.1016/j.cell.2009.03.045] [PMID: 19379690]

Hindy, E.N.; Keyvani, K.; Pagenstecher, A.; Dammann, P.; Sandalcioglu, I.E.; Sure, U.; Zhu, Y. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. Neuro-oncol., 2013, 15(10), 1366-1378.
[http://dx.doi.org/10.1093/neuonc/not071] [PMID: 23787764]

Hulleman, E.; Quarto, M.; Vernell, R.; Masserdotti, G.; Colli, E.; Kros, J.M.; Levi, D.; Gaetani, P.; Tunici, P.; Finocchiaro, G.; Baena, R.R.; Capra, M.; Helin, K. A role for the transcription factor HEY1 in glioblastoma. J. Cell. Mol. Med., 2009, 13(1), 136-146.
[http://dx.doi.org/10.1111/j.1582-4934.2008.00307.x] [PMID: 18363832]

Xing, Z.; Sun, L.; Guo, W. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients. Clin. Neurol. Neurosurg., 2015, 131, 54-58.
[http://dx.doi.org/10.1016/j.clineuro.2015.01.018] [PMID: 25704190]

Dell’Albani, P.; Rodolico, M.; Pellitteri, R.; Tricarichi, E.; Torrisi, S.A.; D’Antoni, S.; Zappia, M.; Albanese, V.; Caltabiano, R.; Platania, N.; Aronica, E.; Catania, M.V. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. Neuro-oncol., 2014, 16(2), 204-216.
[http://dx.doi.org/10.1093/neuonc/not168] [PMID: 24305720]

Cheng, W.; Zhang, C.; Ren, X.; Jiang, Y.; Han, S.; Liu, Y.; Cai, J.; Li, M.; Wang, K.; Liu, Y.; Hu, H.; Li, Q.; Yang, P.; Bao, Z.; Wu, A. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. J. Neurosurg., 2017, 126(1), 249-259.
[http://dx.doi.org/10.3171/2015.11.JNS15432] [PMID: 26967788]

Verhaak, R.G.W.; Hoadley, K.A.; Purdom, E.; Wang, V.; Qi, Y.; Wilkerson, M.D.; Miller, C.R.; Ding, L.; Golub, T.; Mesirov, J.P.; Alexe, G.; Lawrence, M.; O’Kelly, M.; Tamayo, P.; Weir, B.A.; Gabriel, S.; Winckler, W.; Gupta, S.; Jakkula, L.; Feiler, H.S.; Hodgson, J.G.; James, C.D.; Sarkaria, J.N.; Brennan, C.; Kahn, A.; Spellman, P.T.; Wilson, R.K.; Speed, T.P.; Gray, J.W.; Meyerson, M.; Getz, G.; Perou, C.M.; Hayes, D.N. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 2010, 17(1), 98-110.
[http://dx.doi.org/10.1016/j.ccr.2009.12.020] [PMID: 20129251]

Cooper, L.A.D.; Gutman, D.A.; Long, Q.; Johnson, B.A.; Cholleti, S.R.; Kurc, T.; Saltz, J.H.; Brat, D.J.; Moreno, C.S. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PLoS One, 2010, 5(9), e12548.
[http://dx.doi.org/10.1371/journal.pone.0012548] [PMID: 20838435]

Ohgaki, H.; Kleihues, P. The definition of primary and secondary glioblastoma. Clin. Cancer Res., 2013, 19(4), 764-772.
[http://dx.doi.org/10.1158/1078-0432.CCR-12-3002] [PMID: 23209033]

Spino, M.; Kurz, S.C.; Chiriboga, L.; Serrano, J.; Zeck, B.; Sen, N.; Patel, S.; Shen, G.; Vasudevaraja, V.; Tsirigos, A. Cell surface notch ligand DLL3 is a therapeutic target in isocitrate dehydrogenase-mutant glioma. Clin. Cancer Res., 2019, 25(4), 1261-1271.
[PMID: 30397180]

Han, N.; Hu, G.; Shi, L.; Long, G.; Yang, L.; Xi, Q.; Guo, Q.; Wang, J.; Dong, Z.; Zhang, M. Notch1 ablation radiosensitizes glioblastoma cells. Oncotarget, 2017, 8(50), 88059-88068.
[http://dx.doi.org/10.18632/oncotarget.21409] [PMID: 29152141]

(a) Honorato, JR; Davis, HRA; Saggioro, EM Role of Sonic hedgehog signaling in cell cycle, oxidative stress, and autophagy of temozolomide resistant glioblastoma. J Cell Physiol, 2020, 235(4), 3798-814.
[http://dx.doi.org/10.1002/jcp.29274] [PMID: 31613002];
(b) Dali, R.; Verginelli, F.; Pramatarova, A.; Sladek, R.; Stifani, v. Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma-initiating cells. Mol Oncol., 2018, 12(6), 775-787.
[http://dx.doi.org/10.1002/1878-0261.12168]

Melamed, J.R.; Morgan, J.T.; Ioele, S.A.; Gleghorn, J.P.; Mourtada, S.J.; Day, E.S. Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide. Oncotarget, 2018, 9(43), 27000-27015.
[http://dx.doi.org/10.18632/oncotarget.25467] [PMID: 29930746]

Skoda, A.M.; Simovic, D.; Karin, V.; Kardum, V.; Vranic, S.; Serman, L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn. J. Basic Med. Sci., 2018, 18(1), 8-20.
[http://dx.doi.org/10.17305/bjbms.2018.2756] [PMID: 29274272]

Liu, S.; Dontu, G.; Mantle, I.D.; Patel, S.; Ahn, N.; Jackson, K.W.; Suri, P.; Wicha, M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res., 2006, 66(12), 6063-6071.
[http://dx.doi.org/10.1158/0008-5472.CAN-06-0054] [PMID: 16778178]

Onishi, H.; Katano, M. Hedgehog signaling pathway as a therapeutic target in various types of cancer. Cancer Sci., 2011, 102(10), 1756-1760.
[http://dx.doi.org/10.1111/j.1349-7006.2011.02010.x] [PMID: 21679342]

Xu, Q.; Yuan, X.; Liu, G.; Black, K.L.; Yu, J.S. Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas. Stem Cells, 2008, 26(12), 3018-3026.
[http://dx.doi.org/10.1634/stemcells.2008-0459] [PMID: 18787206]

Hung, H.C.; Liu, C.C.; Chuang, J.Y.; Su, C.L.; Gean, P.W. Inhibition of sonic hedgehog signaling suppresses glioma stem-like cells likely through inducing autophagic cell death. Front. Oncol., 2020, 10, 1233.
[http://dx.doi.org/10.3389/fonc.2020.01233] [PMID: 32793494]

Ferruzzi, P.; Mennillo, F.; Rosa, D.A.; Giordano, C.; Rossi, M.; Benedetti, G.; Magrini, R.; Mohr, G.P.; Miragliotta, V.; Magnoni, L.; Mori, E.; Thomas, R.; Tunici, P.; Bakker, A. In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines. Int. J. Cancer, 2012, 131(2), E33-E44.
[http://dx.doi.org/10.1002/ijc.27349] [PMID: 22072503]

Nanta, R.; Shrivastava, A.; Sharma, J.; Shankar, S.; Srivastava, R.K. Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells. Mol. Cell. Biochem., 2019, 454(1-2), 11-23.
[http://dx.doi.org/10.1007/s11010-018-3448-z] [PMID: 30251117]

Matsui, W.H. Cancer stem cell signaling pathways. Medicine, 2016, 95(S1), S8-S19.
[http://dx.doi.org/10.1097/MD.0000000000004765] [PMID: 27611937]

Chakravarti, A.; Zhai, G.; Suzuki, Y.; Sarkesh, S.; Black, P.M.; Muzikansky, A.; Loeffler, J.S. The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J. Clin. Oncol., 2004, 22(10), 1926-1933.
[http://dx.doi.org/10.1200/JCO.2004.07.193] [PMID: 15143086]

Thorpe, L.M.; Yuzugullu, H.; Zhao, J.J. PI3K in cancer: Divergent roles of isoforms, modes of activation and therapeutic targeting. Nat. Rev. Cancer, 2015, 15(1), 7-24.
[http://dx.doi.org/10.1038/nrc3860] [PMID: 25533673]

Gavgani, M.F.; Arnesen, S.V.; Jacobsen, R.G.; Krakstad, C.; Hoivik, E.A.; Lewis, A.E.; Class, I. Class I phosphoinositide 3-kinase PIK3CA/p110α and PIK3CB/p110β isoforms in endometrial cancer. Int. J. Mol. Sci., 2018, 19(12), 3931.
[http://dx.doi.org/10.3390/ijms19123931] [PMID: 30544563]

Holland, E.C.; Celestino, J.; Dai, C.; Schaefer, L.; Sawaya, R.E.; Fuller, G.N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet., 2000, 25(1), 55-57.
[http://dx.doi.org/10.1038/75596] [PMID: 10802656]

Hambardzumyan, D.; Becher, O.J.; Rosenblum, M.K.; Pandolfi, P.P.; Todorova, M.K.; Holland, E.C. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev., 2008, 22(4), 436-448.
[http://dx.doi.org/10.1101/gad.1627008] [PMID: 18281460]

Wei, Y.; Jiang, Y.; Zou, F.; Liu, Y.; Wang, S.; Xu, N.; Xu, W.; Cui, C.; Xing, Y.; Liu, Y.; Cao, B.; Liu, C.; Wu, G.; Ao, H.; Zhang, X.; Jiang, J. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc. Natl. Acad. Sci., 2013, 110(17), 6829-6834.
[http://dx.doi.org/10.1073/pnas.1217002110] [PMID: 23569237]

Phillips, H.S.; Kharbanda, S.; Chen, R.; Forrest, W.F.; Soriano, R.H.; Wu, T.D.; Misra, A.; Nigro, J.M.; Colman, H.; Soroceanu, L.; Williams, P.M.; Modrusan, Z.; Feuerstein, B.G.; Aldape, K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 2006, 9(3), 157-173.
[http://dx.doi.org/10.1016/j.ccr.2006.02.019] [PMID: 16530701]

Akhurst, R.J.; Hata, A. Targeting the TGFβ signalling pathway in disease. Nat. Rev. Drug Discov., 2012, 11(10), 790-811.
[http://dx.doi.org/10.1038/nrd3810] [PMID: 23000686]

Ihle, N.T.; Lemos, R., Jr; Wipf, P.; Yacoub, A.; Mitchell, C.; Siwak, D.; Mills, G.B.; Dent, P.; Kirkpatrick, D.L.; Powis, G. Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance. Cancer Res., 2009, 69(1), 143-150.
[http://dx.doi.org/10.1158/0008-5472.CAN-07-6656] [PMID: 19117997]

Yang, L.; Moses, H.L. Transforming growth factor β: Tumor suppressor or promoter? Are host immune cells the answer? Cancer Res., 2008, 68(22), 9107-9111.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-2556] [PMID: 19010878]

Bellomo, C.; Caja, L.; Moustakas, A. Transforming growth factor β as regulator of cancer stemness and metastasis. Br. J. Cancer, 2016, 115(7), 761-769.
[http://dx.doi.org/10.1038/bjc.2016.255] [PMID: 27537386]

Dijke, P.; Hill, C.S. New insights into TGF-β–Smad signalling. Trends Biochem. Sci., 2004, 29(5), 265-273.
[http://dx.doi.org/10.1016/j.tibs.2004.03.008] [PMID: 15130563]

Peñuelas, S.; Anido, J.; Sánchez, P.R.M.; Folch, G.; Barba, I.; Cuartas, I.; Dorado, G.D.; Poca, M.A.; Sahuquillo, J.; Baselga, J.; Seoane, J. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell, 2009, 15(4), 315-327.
[http://dx.doi.org/10.1016/j.ccr.2009.02.011] [PMID: 19345330]

Iwadate, Y.; Matsutani, T.; Hirono, S.; Shinozaki, N.; Saeki, N. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma. J. Neurooncol., 2016, 129(1), 101-107.
[http://dx.doi.org/10.1007/s11060-016-2145-6] [PMID: 27193555]

Chao, M.; Liu, N.; Sun, Z.; Jiang, Y.; Jiang, T.; Xv, M.; Jia, L.; Tu, Y.; Wang, L. TGF-β signaling promotes glioma progression through stabilizing Sox9. Front. Immunol., 2021, 11, 592080.
[http://dx.doi.org/10.3389/fimmu.2020.592080] [PMID: 33613515]

Bruna, A.; Darken, R.S.; Rojo, F.; Ocaña, A.; Peñuelas, S.; Arias, A.; Paris, R.; Tortosa, A.; Mora, J.; Baselga, J.; Seoane, J. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell, 2007, 11(2), 147-160.
[http://dx.doi.org/10.1016/j.ccr.2006.11.023] [PMID: 17292826]

Ikushima, H.; Todo, T.; Ino, Y.; Takahashi, M.; Miyazawa, K.; Miyazono, K. Autocrine TGF-β signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell, 2009, 5(5), 504-514.
[http://dx.doi.org/10.1016/j.stem.2009.08.018] [PMID: 19896441]

Scadden, DT The stem-cell niche as an entity of action. Nature, 2006, 441(7097), 1075-1079.
[http://dx.doi.org/10.1038/nature04957]

Gilbertson, R.J.; Rich, J.N. Making a tumour’s bed: Glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer, 2007, 7(10), 733-736.
[http://dx.doi.org/10.1038/nrc2246] [PMID: 17882276]

Martinez, P.; Ballarin, L.; Ereskovsky, A.V.; Gazave, E.; Hobmayer, B.; Manni, L.; Rottinger, E.; Sprecher, S.G.; Tiozzo, S.; Coelho, V.A.; Rinkevich, B. Articulating the “stem cell niche” paradigm through the lens of non-model aquatic invertebrates. BMC Biol., 2022, 20(1), 23.
[http://dx.doi.org/10.1186/s12915-022-01230-5] [PMID: 35057814]

Llorente, V.; Velarde, P.; Desco, M.; Gaviro, G.M.V. Current understanding of the neural stem cell niches. Cells, 2022, 11(19), 3002.
[http://dx.doi.org/10.3390/cells11193002] [PMID: 36230964]

Fidoamore, A.; Cristiano, L.; Antonosante, A.; d’Angelo, M.; Giacomo, D.E.; Astarita, C.; Giordano, A.; Ippoliti, R.; Benedetti, E.; Cimini, A. Glioblastoma stem cells microenvironment: The paracrine roles of the niche in drug and radioresistance. Stem Cells Int., 2016, 2016(1), 6809105.
[http://dx.doi.org/10.1155/2016/6809105] [PMID: 26880981]

Castillejo, R.C.; Sánchez, S.F.; Agulló, A.C.; Ferrón, S.R.; Aguilar, A.J.D.; Sánchez, P.; Mira, H.; Escribano, J.; Fariñas, I. Pigment epithelium–derived factor is a niche signal for neural stem cell renewal. Nat. Neurosci., 2006, 9(3), 331-339.
[http://dx.doi.org/10.1038/nn1657] [PMID: 16491078]

Tavazoie, M.; Veken, V.D.L.; Vargas, S.V.; Louissaint, M.; Colonna, L.; Zaidi, B.; Verdugo, G.J.M.; Doetsch, F. A specialized vascular niche for adult neural stem cells. Cell Stem Cell, 2008, 3(3), 279-288.
[http://dx.doi.org/10.1016/j.stem.2008.07.025] [PMID: 18786415]

Doetsch, F. A niche for adult neural stem cells. Curr. Opin. Genet. Dev., 2003, 13(5), 543-550.
[http://dx.doi.org/10.1016/j.gde.2003.08.012] [PMID: 14550422]

Fan, X.; Khaki, L.; Zhu, T.S.; Soules, M.E.; Talsma, C.E.; Gul, N.; Koh, C.; Zhang, J.; Li, Y.M.; Maciaczyk, J.; Nikkhah, G.; DiMeco, F.; Piccirillo, S.; Vescovi, A.L.; Eberhart, C.G. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells, 2010, 28(1), 5-16.
[http://dx.doi.org/10.1002/stem.254] [PMID: 19904829]

Gonzalez, P.P; Asrican, B; Rodriguez, E; Kuo, CT Identification of distinct ChAT+ neurons and activity-dependent control of postnatal SVZ neurogenesis. Nat Neurosci., 2014, 17(7), 934-942.

Llaguno, A.S.R.; Wang, Z.; Sun, D.; Chen, J.; Xu, J.; Kim, E.; Hatanpaa, K.J.; Raisanen, J.M.; Burns, D.K.; Johnson, J.E.; Parada, L.F. Adult lineage-restricted CNS progenitors specify distinct glioblastoma subtypes. Cancer Cell, 2015, 28(4), 429-440.
[http://dx.doi.org/10.1016/j.ccell.2015.09.007] [PMID: 26461091]

Roesler, R. Interplay between neural stem cells and glioblastoma: Possible role of neurotrophin signaling. Clin. Transl. Oncol., 2019, 21(11), 1578-1579.
[http://dx.doi.org/10.1007/s12094-019-02206-8] [PMID: 31571153]

Jiang, Y.; Marinescu, V.D.; Xie, Y.; Jarvius, M.; Maturi, N.P.; Haglund, C.; Olofsson, S.; Lindberg, N.; Olofsson, T.; Leijonmarck, C.; Hesselager, G.; Alafuzoff, I.; Fryknäs, M.; Larsson, R.; Nelander, S.; Uhrbom, L. Glioblastoma cell malignancy and drug sensitivity are affected by the cell of origin. Cell Rep., 2017, 18(4), 977-990.
[http://dx.doi.org/10.1016/j.celrep.2017.01.003] [PMID: 28122246]

Llaguno, A.S.R.; Parada, L.F. Cell of origin of glioma: Biological and clinical implications. Br. J. Cancer, 2016, 115(12), 1445-1450.
[http://dx.doi.org/10.1038/bjc.2016.354] [PMID: 27832665]

Matarredona, E.R.; Pastor, A.M. Neural stem cells of the subventricular zone as the origin of human glioblastoma stem cells. Therapeutic implications. Front. Oncol., 2019, 9, 779.
[http://dx.doi.org/10.3389/fonc.2019.00779] [PMID: 31482066]

Liu, C.; Sage, J.C.; Miller, M.R.; Verhaak, R.G.W.; Hippenmeyer, S.; Vogel, H.; Foreman, O.; Bronson, R.T.; Nishiyama, A.; Luo, L.; Zong, H. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell, 2011, 146(2), 209-221.
[http://dx.doi.org/10.1016/j.cell.2011.06.014] [PMID: 21737130]

Lee, JH; Lee, JH. The origin-of-cell harboring cancer-driving mutations in human glioblastoma. BMB Rep, 2018, 51(10), 481-3.
[http://dx.doi.org/10.5483/BMBRep.2018.51.10.233] [PMID: 30269745]

Modrek, A.S.; Golub, D.; Khan, T.; Bready, D.; Prado, J.; Bowman, C.; Deng, J.; Zhang, G.; Rocha, P.P.; Raviram, R.; Lazaris, C.; Stafford, J.M.; LeRoy, G.; Kader, M.; Dhaliwal, J.; Bayin, N.S.; Frenster, J.D.; Serrano, J.; Chiriboga, L.; Baitalmal, R.; Nanjangud, G.; Chi, A.S.; Golfinos, J.G.; Wang, J.; Karajannis, M.A.; Bonneau, R.A.; Reinberg, D.; Tsirigos, A.; Zagzag, D.; Snuderl, M.; Skok, J.A.; Neubert, T.A.; Placantonakis, D.G. Low-grade astrocytoma mutations in IDH1, P53, and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Rep., 2017, 21(5), 1267-1280.
[http://dx.doi.org/10.1016/j.celrep.2017.10.009] [PMID: 29091765]

Verdugo, E.; Puerto, I.; Medina, M.Á. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. Cancer Commun., 2022, 42(11), 1083-1111.
[http://dx.doi.org/10.1002/cac2.12361] [PMID: 36129048]

Bulstrode, H.; Johnstone, E.; Torrejon, M.M.A.; Ferguson, K.M.; Bressan, R.B.; Blin, C.; Grant, V.; Gogolok, S.; Gangoso, E.; Gagrica, S.; Ender, C.; Fotaki, V.; Sproul, D.; Bertone, P.; Pollard, S.M. Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators. Genes Dev., 2017, 31(8), 757-773.
[http://dx.doi.org/10.1101/gad.293027.116] [PMID: 28465359]

Yang, R.; Chen, L.H.; Hansen, L.J.; Carpenter, A.B.; Moure, C.J.; Liu, H.; Pirozzi, C.J.; Diplas, B.H.; Waitkus, M.S.; Greer, P.K.; Zhu, H.; McLendon, R.E.; Bigner, D.D.; He, Y.; Yan, H. Cic loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation. Cancer Res., 2017, 77(22), 6097-6108.
[http://dx.doi.org/10.1158/0008-5472.CAN-17-1018] [PMID: 28939681]

Yan, W.; Wu, X.; Zhou, W.; Fong, M.Y.; Cao, M.; Liu, J.; Liu, X.; Chen, C.H.; Fadare, O.; Pizzo, D.P.; Wu, J.; Liu, L.; Liu, X.; Chin, A.R.; Ren, X.; Chen, Y.; Locasale, J.W.; Wang, S.E. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat. Cell Biol., 2018, 20(5), 597-609.
[http://dx.doi.org/10.1038/s41556-018-0083-6] [PMID: 29662176]

Wang, J.; Liu, J.; Sun, G.; Meng, H.; Wang, J.; Guan, Y.; Yin, Y.; Zhao, Z.; Dong, X.; Yin, S.; Li, H.; Cheng, Y.; Wu, H.; Wu, A.; Yu, X.; Chen, L. Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells. Cancer Lett., 2019, 466, 1-12.
[http://dx.doi.org/10.1016/j.canlet.2019.09.004] [PMID: 31521694]

(a) Qin, EY; Cooper, DD; Abbott, KL Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma. Cell., 2017, 170(5), 845-859.e19.
[http://dx.doi.org/10.1016/j.cell.2017.07.016];
(b) Zhang, GL; Wang, CF; Qian, C; Ji, YX; Wang, YZ Role and mechanism of neural stem cells of the subventricular zone in glioblastoma. World J Stem Cells, 2021, 13(7), 877-893.
[http://dx.doi.org/10.4252/wjsc.v13.i7.877] [PMID: 34367482]

Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.B.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R.C.; Ludwin, S.K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J.G.; Eisenhauer, E.; Mirimanoff, R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 2005, 352(10), 987-996.
[http://dx.doi.org/10.1056/NEJMoa043330] [PMID: 15758009]

Thakkar, J.P.; Dolecek, T.A.; Horbinski, C.; Ostrom, Q.T.; Lightner, D.D.; Sloan, B.J.S.; Villano, J.L. Epidemiologic and molecular prognostic review of glioblastoma. Canc. Epidemiol. Biomarkers Prev., 2014, 23(10), 1985-1996.
[http://dx.doi.org/10.1158/1055-9965.EPI-14-0275] [PMID: 25053711]

Ghosh, D.; Nandi, S.; Bhattacharjee, S. Combination therapy to checkmate Glioblastoma: Clinical challenges and advances. Clin. Transl. Med., 2018, 7(1), e33.
[http://dx.doi.org/10.1186/s40169-018-0211-8] [PMID: 30327965]

Bindra, R.S.; Chalmers, A.J.; Evans, S.; Dewhirst, M. GBM radiosensitizers: Dead in the water…or just the beginning? J. Neurooncol., 2017, 134(3), 513-521.
[http://dx.doi.org/10.1007/s11060-017-2427-7] [PMID: 28762004]

Curtis, M.A.; Kam, M.; Nannmark, U.; Anderson, M.F.; Axell, M.Z.; Wikkelso, C.; Holtås, S.; van Roon-Mom, W.M.C.; Eriksson, B.T.; Nordborg, C.; Frisén, J.; Dragunow, M.; Faull, R.L.M.; Eriksson, P.S. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science, 2007, 315(5816), 1243-1249.
[http://dx.doi.org/10.1126/science.1136281] [PMID: 17303719]

Mutukula, N.; Elkabetz, Y. “Neural Killer” cells: Autologous cytotoxic neural stem cells for fighting glioma. Cell Stem Cell, 2017, 20(4), 426-428.
[http://dx.doi.org/10.1016/j.stem.2017.03.019] [PMID: 28388425]

Cameron, B.D.; Traver, G.; Roland, J.T.; Brockman, A.A.; Dean, D.; Johnson, L.; Boyd, K.; Ihrie, R.A.; Freeman, M.L. Bcl2-expressing quiescent type B neural stem cells in the ventricular–subventricular zone are resistant to concurrent temozolomide/X-irradiation. Stem Cells, 2019, 37(12), 1629-1639.
[http://dx.doi.org/10.1002/stem.3081] [PMID: 31430423]

Muracciole, X.; amine, E.W.; Tabouret, E.; Boucekine, M.; Barlier, A.; Petrirena, G.; Harivony, T.; Solignac, L.; Chinot, O.L.; Macagno, N.; Branger, F.D.; Padovani, L. Negative survival impact of high radiation doses to neural stem cells niches in an IDH-wild-type glioblastoma population. Front. Oncol., 2018, 8, 426.
[http://dx.doi.org/10.3389/fonc.2018.00426] [PMID: 30338243]

Cho, N.; Wang, C.; Raymond, C.; Kaprealian, T.; Ji, M.; Salamon, N.; Pope, W.B.; Nghiemphu, P.L.; Lai, A.; Cloughesy, T.F.; Ellingson, B.M. Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement. J. Neurooncol., 2020, 147(3), 643-652.
[http://dx.doi.org/10.1007/s11060-020-03460-5] [PMID: 32239430]

Bagó, J.R.; Okolie, O.; Dumitru, R.; Ewend, M.G.; Parker, J.S.; Werff, R.V.; Underhill, T.M.; Schmid, R.S.; Miller, C.R.; Hingtgen, S.D. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. Sci. Transl. Med., 2017, 9(375), eaah6510.
[http://dx.doi.org/10.1126/scitranslmed.aah6510] [PMID: 28148846]

Spencer, D.; Yu, D.; Morshed, R.A.; Li, G.; Pituch, K.C.; Gao, D.X.; Bertolino, N.; Procissi, D.; Lesniak, M.S.; Balyasnikova, I.V. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma. Theranostics, 2019, 9(7), 2071-2083.
[http://dx.doi.org/10.7150/thno.29581] [PMID: 31037157]

Sheets, K.T.; Ewend, M.G.; Asli, M.M.; Tuin, S.A.; Loboa, E.G.; Aboody, K.S.; Hingtgen, S.D. Developing implantable scaffolds to enhance neural stem cell therapy for post-operative glioblastoma. Mol. Ther., 2020, 28(4), 1056-1067.
[http://dx.doi.org/10.1016/j.ymthe.2020.02.008] [PMID: 32109370]

Goffart, N.; Kroonen, J.; Valentin, D.E.; Dedobbeleer, M.; Denne, A.; Martinive, P.; Rogister, B. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling. Neuro-oncol., 2015, 17(1), 81-94.
[http://dx.doi.org/10.1093/neuonc/nou144] [PMID: 25085362]

Gravina, G.L.; Mancini, A.; Colapietro, A.; Vitale, F.; Vetuschi, A.; Pompili, S.; Rossi, G.; Marampon, F.; Richardson, P.J.; Patient, L.; Patient, L.; Burbidge, S.; Festuccia, C. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol., 2017, 39(6), 1010428317695528.
[http://dx.doi.org/10.1177/1010428317695528] [PMID: 28639900]

Chen, L.; Cazares, G.H.; Ye, X.; Ford, E.; McNutt, T.; Kleinberg, L.; Lim, M.; Chaichana, K.; Hinojosa, Q.A.; Redmond, K. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int. J. Radiat. Oncol. Biol. Phys., 2013, 86(4), 616-622.
[http://dx.doi.org/10.1016/j.ijrobp.2013.02.014] [PMID: 23540348]

Ohno, M.; Kitanaka, C.; Miyakita, Y.; Tanaka, S.; Sonoda, Y.; Mishima, K.; Ishikawa, E.; Takahashi, M.; Yanagisawa, S.; Ohashi, K.; Nagane, M.; Narita, Y. Metformin with temozolomide for newly diagnosed glioblastoma: Results of phase I study and a brief review of relevant studies. Cancers, 2022, 14(17), 4222.
[http://dx.doi.org/10.3390/cancers14174222] [PMID: 36077758]

Yang, C.; Ko, B.; Hensley, C.T.; Jiang, L.; Wasti, A.T.; Kim, J.; Sudderth, J.; Calvaruso, M.A.; Lumata, L.; Mitsche, M.; Rutter, J.; Merritt, M.E.; DeBerardinis, R.J. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell, 2014, 56(3), 414-424.
[http://dx.doi.org/10.1016/j.molcel.2014.09.025] [PMID: 25458842]

Griguer, C.E.; Cantor, A.B.; Shaykh, F.H.M.; Gillespie, G.Y.; Gordon, A.S.; Markert, J.M.; Radovanovic, I.; Schatlo, C.V.; Shannon, C.N.; Oliva, C.R. Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme. PLoS One, 2013, 8(4), e61035.
[http://dx.doi.org/10.1371/journal.pone.0061035] [PMID: 23593382]

Mistry, A.M. On the subventricular zone origin of human glioblastoma. Transl. Cancer Res., 2019, 8(1), 11-13.
[http://dx.doi.org/10.21037/tcr.2018.11.31] [PMID: 30873355]

Fan, H.C.; Chen, C.M.; Chi, C.S.; Tsai, J.D.; Chiang, K.L.; Chang, Y.K.; Lin, S.Z.; Harn, H.J. Targeting telomerase and ATRX/DAXX inducing tumor senescence and apoptosis in the malignant glioma. Int. J. Mol. Sci., 2019, 20(1), 200.
[http://dx.doi.org/10.3390/ijms20010200] [PMID: 30625996]

Salloum, R.; Hummel, T.R.; Kumar, S.S.; Dorris, K.; Li, S.; Lin, T.; Daryani, V.M.; Stewart, C.F.; Miles, L.; Poussaint, T.Y.; Stevenson, C.; Goldman, S.; Dhall, G.; Packer, R.; Fisher, P.; Pollack, I.F.; Fouladi, M.; Boyett, J.; Drissi, R. A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: A pediatric brain tumor consortium study. J. Neurooncol., 2016, 129(3), 443-451.
[http://dx.doi.org/10.1007/s11060-016-2189-7] [PMID: 27350411]

Yen, S-Y.; Chen, S-R.; Hsieh, J.; Li, Y-S.; Chuang, S-E.; Chuang, H-M.; Huang, M-H.; Lin, S-Z.; Harn, H-J.; Chiou, T-W. Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion. Oncogene, 2016, 35(17), 2156-2165.
[http://dx.doi.org/10.1038/onc.2015.277] [PMID: 26257061]

Meijer, DH; Maguire, CA; Leroy, SG; Esteves, S.M Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-β. Canc. Gene Ther., 2009, 16(8), 664-671.
[http://dx.doi.org/10.1038/cgt.2009.8]

Kim, D.G.; Kim, K.H.; Seo, Y.J.; Yang, H.; Marcusson, E.G.; Son, E.; Lee, K.; Sa, J.K.; Lee, H.W.; Nam, D.H. Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy. Oncotarget, 2016, 7(20), 29400-29411.
[http://dx.doi.org/10.18632/oncotarget.8837] [PMID: 27102443]

Brown, C.E.; Aguilar, B.; Starr, R.; Yang, X.; Chang, W.C.; Weng, L.; Chang, B.; Sarkissian, A.; Brito, A.; Sanchez, J.F.; Ostberg, J.R.; D’Apuzzo, M.; Badie, B.; Barish, M.E.; Forman, S.J. Optimization of IL13Rα2-targeted chimeric antigen receptor T cells for improved anti-tumor efficacy against glioblastoma. Mol. Ther., 2018, 26(1), 31-44.
[http://dx.doi.org/10.1016/j.ymthe.2017.10.002] [PMID: 29103912]

Portnow J. A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E. Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas. 2010, Available from: https://clinicaltrials.gov/ct2/show/NCT01172964.

Genetically modified neural stem cells, flucytosine, and leucovorin for treating patients with recurrent high-grade gliomas. Available from: https://clinicaltrials.gov/ct2/show/NCT02015819

Neural stem cell based virotherapy of newly diagnosed malignant glioma. Available from: https://clinicaltrials.gov/ct2/show/NCT03072134

Oncolytic adenovirus DNX-2401 in treating patients with recurrent high-grade glioma. Available from: https://clinicaltrials.gov/ct2/show/NCT03896568

Bexell, D.; Gunnarsson, S.; Svensson, A.; Tormin, A.; Oliveira, H.C.; Siesjö, P.; Paul, G.; Salford, L.G.; Scheding, S.; Bengzon, J. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. Neurosurgery, 2012, 70(3), 731-739.
[http://dx.doi.org/10.1227/NEU.0b013e318232dedd] [PMID: 21869725]

Gutova, M.; Flores, L.; Adhikarla, V.; Tsaturyan, L.; Tirughana, R.; Aramburo, S.; Metz, M.; Gonzaga, J.; Annala, A.; Synold, T.W.; Portnow, J.; Rockne, R.C.; Aboody, K.S. Quantitative evaluation of intraventricular delivery of therapeutic neural stem cells to orthotopic glioma. Front. Oncol., 2019, 9, 68.
[http://dx.doi.org/10.3389/fonc.2019.00068] [PMID: 30838174]

Panciani, P.P.; Fontanella, M.; Tamagno, I.; Battaglia, L.; Garbossa, D.; Inghirami, G.; Fagioli, F.; Pagano, M.; Ducati, A.; Lanotte, M. Stem cells based therapy in high grade glioma: Why the intraventricular route should be preferred? J. Neurosurg. Sci., 2012, 56(3), 221-229.
[PMID: 22854590]

Klopp, A.H.; Gupta, A.; Spaeth, E.; Andreeff, M.; Marini, F., III Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth? Stem Cells, 2011, 29(1), 11-19.
[http://dx.doi.org/10.1002/stem.559] [PMID: 21280155]

Chang, E.L.; Wefel, J.S.; Hess, K.R.; Allen, P.K.; Lang, F.F.; Kornguth, D.G.; Arbuckle, R.B.; Swint, J.M.; Shiu, A.S.; Maor, M.H.; Meyers, C.A. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol., 2009, 10(11), 1037-1044.
[http://dx.doi.org/10.1016/S1470-2045(09)70263-3] [PMID: 19801201]

Fares, J.; Ahmed, A.U.; Ulasov, I.V.; Sonabend, A.M.; Miska, J.; Chang, L.C.; Balyasnikova, I.V.; Chandler, J.P.; Portnow, J.; Tate, M.C.; Kumthekar, P.; Lukas, R.V.; Grimm, S.A.; Adams, A.K.; Hébert, C.D.; Strong, T.V.; Amidei, C.; Arrieta, V.A.; Zannikou, M.; Horbinski, C.; Zhang, H.; Burdett, K.B.; Curiel, D.T.; Sachdev, S.; Aboody, K.S.; Stupp, R.; Lesniak, M.S. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: A first-in-human, phase 1, dose-escalation trial. Lancet Oncol., 2021, 22(8), 1103-1114.
[http://dx.doi.org/10.1016/S1470-2045(21)00245-X] [PMID: 34214495]